This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Postnatal investigation, monitoring and treatment of gestational hypertension

Authoring team

Postnatal investigation, monitoring and treatment

  • in women with gestational hypertension who have given birth, measure blood pressure:
    • daily for the first 2 days after birth
    • at least once between day 3 and day 5 after birth
    • as clinically indicated if antihypertensive treatment is changed after birth

  • in women with gestational hypertension who have given birth:
    • continue antihypertensive treatment if required
    • advise women that the duration of their postnatal antihypertensive treatment will usually be similar to the duration of their antenatal treatment (but may be longer)
    • reduce antihypertensive treatment if their blood pressure falls below 130/80 mmHg
  • if a woman has taken methyldopa to treat gestational hypertension, stop within 2 days after the birth and change to an alternative treatment if necessary

  • for women with gestational hypertension who did not take antihypertensive treatment and have given birth, start antihypertensive treatment if their blood pressure is 150/100mmHg or higher

  • offer women who have had gestational hypertension and who remain on antihypertensive treatment, a medical review with their GP or specialist 2 weeks after transfer to community care
  • offer all women who have had gestational hypertension a medical review with their GP or specialist 6-8 weeks after the birth

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.